4//SEC Filing
Gilman Sydney A. 4
Accession 0001235802-19-000131
CIK 0001401040other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:13 PM ET
Size
5.9 KB
Accession
0001235802-19-000131
Insider Transaction Report
Form 4
Gilman Sydney A.
VP, Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2019-11-01+50,000→ 50,000 totalExercise: $4.00Exp: 2029-10-31→ Common Stock (50,000 underlying)
Holdings
- 0
Common Stock
Footnotes (1)
- [F1]Vests in twelve nearly equal quarterly installments over three years.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001793016
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:13 PM ET
- Size
- 5.9 KB